Dave Gardiner
Venture Partner @ Carthona Capital
Sydney, Australia
Dave Gardiner is a funding round investor at Carthona Capital in Sydney focused on RFID and Software. Dave has had over 20 years of global experience in management consulting, IT and supply chain management. Dave was previously Co-Founder and Managing Director at Portland Group, which he recently exited on acquisition by Infosys.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Dave Gardiner invests in
Stages Dave Gardiner invests in
Countries Dave Gardiner invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- RFID 1 (25%)
- Software 1 (25%)
- Health Care 1 (25%)
- Manufacturing 1 (25%)
- Pharmaceutical 1 (25%)
Stage
- Funding Round 2 (50%)
- Seed 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Paratus Clinical
|
Paratus Clinical Pty Ltd has been established to meet an increasing need for local service provision in Australia and New Zealand particularly for early Phase and late Phase (in Primary care) Clinical Research. Paratus Clinical provides clinical trial related services to pharmaceutical companies, contract research organizations (CROs),biotechnology companies, medical device companies and clinical sites. The site may be a single practice, network of practices, hospital based practice or a similar health care institution that has the infrastructure and staff to meet the requirements of the clinical trial protocol.Paratus Clinical has a qualified and experienced team of clinical research professionals who understand the intricacies of conducting clinical trials. Our experience with the entire process, from feasibility to site closeout, enables us to ensure timely and effective delivery at every stage of a trial. Our dedicated research team is comprised of highly skilled research professionals with many years of experience in all phases of trials and in a myriad of clinical indications. | $942K / Oct 25, 2017 | |
Ramp
|
RAMP develops and manufactures radio frequency identification tags, chips, and readers for tracking, locating, and managing equipment, inventory, and people in real-time. It offers RFID-based asset tracking, vehicle tracking, inventory tracking, and project materials tracking solutions.The company was founded in 2006 and is based in Alexandria,Australia. | $337K / Jan 21, 2016 | |
|
Paratus Clinical
|
Paratus Clinical Pty Ltd has been established to meet an increasing need for local service provision in Australia and New Zealand particularly for early Phase and late Phase (in Primary care) Clinical Research. Paratus Clinical provides clinical trial related services to pharmaceutical companies, contract research organizations (CROs),biotechnology companies, medical device companies and clinical sites. The site may be a single practice, network of practices, hospital based practice or a similar health care institution that has the infrastructure and staff to meet the requirements of the clinical trial protocol.Paratus Clinical has a qualified and experienced team of clinical research professionals who understand the intricacies of conducting clinical trials. Our experience with the entire process, from feasibility to site closeout, enables us to ensure timely and effective delivery at every stage of a trial. Our dedicated research team is comprised of highly skilled research professionals with many years of experience in all phases of trials and in a myriad of clinical indications. | Seed / Sep 09, 2015 | |
|
Ramp
|
RAMP develops and manufactures radio frequency identification tags, chips, and readers for tracking, locating, and managing equipment, inventory, and people in real-time. It offers RFID-based asset tracking, vehicle tracking, inventory tracking, and project materials tracking solutions.The company was founded in 2006 and is based in Alexandria,Australia. | $404K / Mar 17, 2015 |
About Carthona Capital
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.Carthona Capital was founded in 2014 when a group of like-minded venture investors came together to invest on a deal-by-deal basis. Since then, Carthona Capital has shifted to a more traditional venture capital fundstructure, and is now deploying its third fund with approximately $400m in funds under management from a mix of Institutional (Superannuation), Family Office and High Net-worth investors.Carthona Capital likes to invest very early - their initial investment into a business is usually at the Pre-Seed, Seed, or Series A stages. Carthona then likes to follow-on strongly and continue to deploy larger amounts of capital as a business matures.
Carthona Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dean Dorrell
Partner
|
|||
Brad Shofer
Venture Partner
|
|||
|
Dave Gardiner
Venture Partner
|
|||
James Synge
Partner
|
|||
Jonathan Chow
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Dave Gardiner invest in?
Dave Gardiner invests primarily in RFID, Software and Health Care startups, most often at Funding Round and Seed stage. Most of the 4 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dave Gardiner?
Public channels for Dave Gardiner include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dave Gardiner last invest?
The most recent investment recorded for Dave Gardiner closed in Oct 2017. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
